Indivior Pharmaceuticals Inc (INDV) NASDAQ
30.75
-0.115(-0.37%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 4.49B |
| Enterprise Value | 4.64B |
| P/E Ratio | 18.57 |
| PEG Ratio | 0.66 |
| Price/Sales Ratio | 3.14 |
| Price/Book Ratio | -39.78 |
| Enterprise/Revenue | 3.26 |
| Enterprise/EBITDA | 13.45 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | 0.17 |
| Operating Margin | 0.24 |
Management Effectiveness
| Return On Assets | 0.17 |
| Return On Equity | -0.99 |
Income Statement
| Revenue | 1.24B |
| Revenue/Share | 9.92 |
| Gross Profit | 994M |
| EBITDA | 304M |
| Net Income | 210M |
| Diluted EPS | 1.64 |
Balance Sheet
| Total Cash | 195M |
| Total Cash/Share | 1.56 |
| Total Debt | 351M |
| Total Debt/Equity | -3.58 |
| Current Ratio | 0.71 |
| Book Value Per Share | -0.78 |
Price History
| 52-Week Change | 225.23 |
| 52-Week High | 38 |
| 52-Week Low | 8.64 |
| Moving Average 50 Days | 33.92 |
| Moving Average 200 Days | 26.21 |
Statistics
| Average Volume | 2.4M |
| Shares Outstanding | 124.77M |
| % Held by Institutions | 90.36 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:5 |
| Last Split Date | October 10, 2022 |
